Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients.
Ogawa T, Nitta K.
Contrib Nephrol. 2015;185:76-86. doi: 10.1159/000380972. Epub 2015 May 19.
PMID:26023017
Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients.
Yajima T, Yajima K, Takahashi H.
PLoS One. 2021 Jan 15;16(1):e0245625. doi: 10.1371/journal.pone.0245625. eCollection 2021.
PMID:33449974
Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis.
Lee HY, Suh SW, Hwang JH, Shin J.
Front Nutr. 2022 Dec 2;9:1044895. doi: 10.3389/fnut.2022.1044895. eCollection 2022.
PMID:36532527
How I treat anemia in pregnancy: iron, cobalamin, and folate.
Achebe MM, Gafter-Gvili A.
Blood. 2017 Feb 23;129(8):940-949. doi: 10.1182/blood-2016-08-672246. Epub 2016 Dec 29.